Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 24-28 , January 2009

Controversies in Surgical Management of the Node-Positive Neck After Chemoradiation

  • Miriam N. Lango, MD

      Affiliations

    • Department of Surgical Oncology, Head and Neck Section, Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Jeffrey N. Myers, MD, PhD

      Affiliations

    • Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
    • Corresponding Author InformationAddress reprint requests to Jeffrey N. Myers, MD, PhD, FACS, Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 441, Houston, TX 77030-4009
    • ,
  • Adam S. Garden, MD

      Affiliations

    • Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

References 

  1. Conley J. Radical neck dissection. Laryngoscope. 1975;85:1344–1352
  2. Davidson BJ, Newkirk KA, Harter KW, et al. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg. 1999;125:401–405
  3. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy (Analysis of wound complications). Arch Otolaryngol Head Neck Surg. 1995;121:162–165
  4. Lavertu P, Bonafede JP, Adelstein DJ, et al. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg. 1998;124:401–406
  5. Morgan JE, Breau RL, Suen JY, et al. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2007;133:10–14
  6. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer—For selected cases only?. Radiother Oncol. 2003;66:57–63
  7. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group(RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  8. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098
  9. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy group phase II trial 99-14. J Clin Oncol. 2005;23:3008–3015
  10. Garden AS, Harris J, Vokes EE, et al. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol. 2004;22:2856–2864
  11. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck. 2003;25:791–798
  12. Koch W, Sidransky D. Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma. Semin Radiat Oncol. 2004;14:130–138
  13. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000;126:950–956
  14. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope. 2005;115:1015–1020
  15. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26:447–455
  16. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:526–531
  17. Robbins KT, Doweck I, Samant S, et al. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965–969
  18. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421–1427
  19. Corry J, Peters L, Fisher R, et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—Results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck. 2008;30:737–742
  20. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys. 2004;58:694–697
  21. Gourin CG, Williams HT, Seabolt WN, et al. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope. 2006;116:705–710
  22. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer. 1994;74:1355–1359
  23. Yao M, Luo P, Hoffman HT, et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol. 2007;30:264–270
  24. Tan A, Adelstein DJ, Rybicki LA, et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg. 2007;133:435–440
  25. Clayman GL, Johnson CJ, Morrison W, et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127:135–139
  26. Adelstein DJ, Saxton JP, Rybicki LA, et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution. J Clin Oncol. 2006;24:1064–1071
  27. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck. 1997;19:559–566
  28. Ellis ER, Mendenhall WM, Rao PV, et al. Incisional or excisional neck-node biopsy before definitive radiotherapy, alone or followed by neck dissection. Head Neck. 1991;13:177–183
  29. Brizel DM, Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: Consensus, controversy, and conundrum. J Clin Oncol. 2006;24:2612–2617
  30. Bernier J, Bataini JP. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy (Analysis of neck disease response in 1646 cases). Radiother Oncol. 1986;6:87–103
  31. Mabanta SR, Menenhall WM, Stringer SP, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591–594
  32. Temam S, Pape E, Janot F, et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;62:1078–1083
  33. Liauw SL, Amdur RJ, Morris CG, et al. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: Salvage in the dissected or undissected neck. Head Neck. 2007;29:715–719
  34. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck. 1998;20:132–137
  35. Doweck I, Robbins KT, Mendenhall WM, et al. Neck level-specific nodal metastases in oropharyngeal cancer: Is there a role for selective neck dissection after definitive radiation therapy?. Head Neck. 2003;25:960–967
  36. Simon C, Goepfert H, Rosenthal DI, et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006;263:313–318
  37. Lango M, Genevieve A, Andrews SA, et al. Post-radiotherapy neck dissection for head and neck squamous cell carcinoma: Pattern of pathologic residual carcinoma and prognosis. 2008;(in press)
  38. Yeung AR, Liauw SL, Amdur RJ, et al. Lymph node-positive head and neck cancer treated with definitive radiotherapy: Can treatment response determine the extent of neck dissection?. Cancer. 2008;112:1076–1082
  39. Stenson KM, Huo D, Blair E, et al. Planned post-chemoradiation neck dissection: Significance of radiation dose. Laryngoscope. 2006;116:33–36

PII: S1053-4296(08)00060-X

doi: 10.1016/j.semradonc.2008.09.005

Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 24-28 , January 2009

Article Tools